Allergan, Sosei suspend clinical development of dementia drug

18th September 2018 Uncategorised 0

Allergan and Sosei are voluntarily suspending clinical development activities with HTL0018318 pending investigation of an unexpected toxicology finding in an animal study involving non-human primates.

More: Allergan, Sosei suspend clinical development of dementia drug
Source: News